SNV4818 in Participants With Advanced Solid Tumors

NCT06736704 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SNV4818
DRUG: Fulvestrant
DRUG: Palbociclib

Sponsor

Pikavation Therapeutics, Inc.